🇺🇸 FDA
Patent

US 10799561

Method for increasing cardiac inflow by administering a compound that binds RXFP1

granted A61KA61K38/2221A61K9/0019

Quick answer

US patent 10799561 (Method for increasing cardiac inflow by administering a compound that binds RXFP1) held by Relaxera Pharmazeutische Gesellschaft mbH & Co. KG expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/2221, A61K9/0019, A61K9/006, A61K9/113